Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2007

01-12-2007 | Preclinical Study

Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk

Authors: Annika Vaclavicek, Justo Lorenzo Bermejo, Barbara Wappenschmidt, Alfons Meindl, Christian Sutter, Rita K. Schmutzler, Marion Kiechle, Peter Bugert, Barbara Burwinkel, Claus R. Bartram, Kari Hemminki, Asta Försti

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access

Abstract

Aneuploidy, an aberrant number of chromosomes, is a very common characteristic of many types of cancers, including tumors of the breast. There is increasing evidence that defects in the spindle assembly checkpoint, which controls correct chromosome segregation between two daughter cells, might contribute to tumorigenesis. In the present study we examined the effect of promoter and coding single nucleotide polymorphisms (SNPs) in six major spindle checkpoint genes (BUB1B, BUB3, CENPE, MAD2L1, MAD2L2, TTK) on familial breast cancer (BC) risk. A case–control study was carried out with a total of nine SNPs using 441 German, familial BC cases and 552 controls matched by age, ethnicity and geographical region. Neither the individual SNPs in the studied genes nor the haplotypes in the BUB1B, CENPE and TTK genes caused any significant effect on the risk of BC. We used the multifactor-dimensionality reduction method in order to identify gene-gene interactions among the six mitotic checkpoint genes, but no association was detected. Therefore, our results indicate that the investigated SNPs in the mitotic checkpoint genes do not affect the risk of familial BC.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
go back to reference Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649CrossRefPubMed Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649CrossRefPubMed
3.
4.
go back to reference Kops GJ, Weaver BA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773–785CrossRefPubMed Kops GJ, Weaver BA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773–785CrossRefPubMed
5.
6.
go back to reference Taylor SS, Scott MI, Holland AJ (2004) The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosome Res 12:599–616CrossRefPubMed Taylor SS, Scott MI, Holland AJ (2004) The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosome Res 12:599–616CrossRefPubMed
7.
go back to reference Baker DJ, Chen J, van Deursen JM (2005) The mitotic checkpoint in cancer and aging: what have mice taught us? Curr Opin Cell Biol 17:583–589CrossRefPubMed Baker DJ, Chen J, van Deursen JM (2005) The mitotic checkpoint in cancer and aging: what have mice taught us? Curr Opin Cell Biol 17:583–589CrossRefPubMed
8.
go back to reference Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM (2003) Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160:341–353CrossRefPubMed Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM (2003) Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160:341–353CrossRefPubMed
9.
go back to reference Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409:355–359CrossRefPubMed Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409:355–359CrossRefPubMed
11.
go back to reference Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E (2006) Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 12:405–410CrossRefPubMed Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E (2006) Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 12:405–410CrossRefPubMed
12.
go back to reference Myrie KA, Percy MJ, Azim JN, Neeley CK, Petty EM (2000) Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett 152:193–199CrossRefPubMed Myrie KA, Percy MJ, Azim JN, Neeley CK, Petty EM (2000) Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett 152:193–199CrossRefPubMed
13.
go back to reference Li Y, Benezra R (1996) Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246–248CrossRefPubMed Li Y, Benezra R (1996) Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246–248CrossRefPubMed
14.
go back to reference Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM (2000) Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29:356–362CrossRefPubMed Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM (2000) Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29:356–362CrossRefPubMed
15.
go back to reference Meindl A (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472–480CrossRefPubMed Meindl A (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472–480CrossRefPubMed
16.
go back to reference Houlston RS, Peto J (2003) The future of association studies of common cancers. Hum Genet 112:434–435PubMed Houlston RS, Peto J (2003) The future of association studies of common cancers. Hum Genet 112:434–435PubMed
17.
go back to reference Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 25:190–202CrossRefPubMed Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 25:190–202CrossRefPubMed
18.
go back to reference Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK, Lau CC (2004) Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 32:e69CrossRefPubMed Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK, Lau CC (2004) Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 32:e69CrossRefPubMed
19.
go back to reference Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D, Li C, Meyerson M, Sellers WR (2004) Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32:e71CrossRefPubMed Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D, Li C, Meyerson M, Sellers WR (2004) Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32:e71CrossRefPubMed
20.
go back to reference Vaclavicek A, Hemminki K, Bartram CR, Wagner K, Wappenschmidt B, Meindl A, Schmutzler RK, Klaes R, Untch M, Burwinkel B, Forsti A (2006) Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab 91:1513–1519CrossRefPubMed Vaclavicek A, Hemminki K, Bartram CR, Wagner K, Wappenschmidt B, Meindl A, Schmutzler RK, Klaes R, Untch M, Burwinkel B, Forsti A (2006) Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab 91:1513–1519CrossRefPubMed
21.
go back to reference Dupont WD, Plummer WD Jr. (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19:589–601CrossRefPubMed Dupont WD, Plummer WD Jr. (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19:589–601CrossRefPubMed
22.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed
23.
go back to reference Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147CrossRefPubMed Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147CrossRefPubMed
24.
go back to reference Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8:28–35CrossRefPubMed Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8:28–35CrossRefPubMed
25.
26.
go back to reference Karlseder J, Rotheneder H, Wintersberger E (1996) Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16:1659–1667PubMed Karlseder J, Rotheneder H, Wintersberger E (1996) Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16:1659–1667PubMed
27.
go back to reference Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38:1043–1048CrossRefPubMed Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38:1043–1048CrossRefPubMed
Metadata
Title
Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
Authors
Annika Vaclavicek
Justo Lorenzo Bermejo
Barbara Wappenschmidt
Alfons Meindl
Christian Sutter
Rita K. Schmutzler
Marion Kiechle
Peter Bugert
Barbara Burwinkel
Claus R. Bartram
Kari Hemminki
Asta Försti
Publication date
01-12-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9496-9

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine